Clinical Trial Update: Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ruxolitinib with azacitidine maintenance for Acute Myeloid Leukemia patients undergoing reduced-intensity allogeneic stem cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: NOT_YET_RECRUITING